Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Pig pathogen added to disease model portfolio
Researchers complete validation of bacterial pathogen.

Researchers at Moredun Scientific have completed the validation of a Streptococcus suis Serotype 2 disease model in weaner piglets. It is hoped that it will prove useful in the formulation of vaccines and studies into therapeutic efficacy.

Streptococcus suis, a bacterial pathogen of pigs, is of great importance to the global pig industry because of the economic ramifications of disease outbreaks and the according effects on the welfare of infected herds. The disease can make the jump to humans if protocols to prevent the spread of blood-borne diseases are not followed.

An outbreak which started in the Sichaun Province of western China in July 2005 led to over two hundred people being infected and 38 fatalities. The disease has also been identified as the most common cause of meningitis in Vietnam.

Serotype 2 is the strain of the disease which has been identified as being responsible for the majority of infections, and no licensed vaccine is currently available.

Head of Animal Health at Moredun Scientific David Reddick said: "We are pleased to extend our disease model portfolio to offer a highly effective model of S.suis infection to our animal health clients supporting their efforts to prevent and control the disease." 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'